Nicholas J Maragakis Selected Research

Nicholas J Maragakis Research Topics

Disease

21	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 02/2002
10	Disease Progression 01/2022 - 09/2006
9	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 04/2004
3	Gliosis 01/2022 - 02/2002
3	Nervous System Diseases (Neurological Disorders) 01/2018 - 04/2009
3	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2017 - 02/2002
3	Spinal Cord Injuries (Spinal Cord Injury) 09/2015 - 07/2011
2	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2012
2	Contusions 09/2015 - 07/2011
2	Stroke (Strokes) 04/2009 - 04/2004
2	Epilepsy (Aura) 04/2009 - 04/2004
1	X-Linked Bulbo-Spinal Atrophy 01/2022
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022
1	Hereditary Spastic Paraplegia 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Embolism (Embolus) 01/2020
1	Leukocytosis (Pleocytosis) 01/2020
1	Neuroinflammatory Diseases 12/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2012
1	Neuromuscular Diseases (Neuromuscular Disease) 06/2012
1	Vascular Diseases (Vascular Disease) 06/2012
1	Hyperlipidemias (Hyperlipidemia) 06/2012
1	Crush Injuries 12/2011
1	Parkinson Disease (Parkinson's Disease) 04/2009
1	Alzheimer Disease (Alzheimer's Disease) 04/2009
1	Weight Loss (Weight Reduction) 12/2007
1	Infections 08/2004
1	Paralysis (Palsy) 08/2004
1	Central Nervous System Neoplasms 04/2004

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2002
6	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 12/2015 - 02/2002
5	Glutamic Acid (Glutamate)FDA Link 12/2011 - 02/2003
3	Pharmaceutical PreparationsIBA 01/2020 - 08/2012
3	Nerve Growth Factors (Neurotrophins)IBA 01/2020 - 12/2007
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2018
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020 - 08/2012
3	Superoxide Dismutase-1IBA 10/2011 - 02/2002
2	Connexin 43 (Connexin43)IBA 01/2022 - 01/2016
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020 - 08/2012
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2017
1	EdaravoneIBA 10/2022
1	tonabersatIBA 01/2022
1	ezogabine (retigabine)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	tofersenIBA 01/2020
1	Investigational DrugsIBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 11/2018
1	Antisense OligonucleotidesIBA 01/2018
1	Superoxide DismutaseIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	RNA (Ribonucleic Acid)IBA 03/2014
1	Messenger RNA (mRNA)IBA 08/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2012
1	Biological ProductsIBA 04/2009
1	CytokinesIBA 01/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2007
1	Insulin-Like PeptidesIBA 12/2007
1	LigandsIBA 03/2006
1	AMPA Receptors (AMPA Receptor)IBA 08/2004
1	CalciumIBA 08/2004
1	Carisoprodol (Soma)FDA LinkGeneric 04/2004
1	EpitopesIBA 04/2004
1	AntibodiesIBA 04/2004
1	N-Methylaspartate (NMDA)IBA 02/2003
1	Glutamate Receptors (Glutamate Receptor)IBA 02/2003
1	Topiramate (Topamax)FDA LinkGeneric 02/2003

Therapy/Procedure

7	Therapeutics 10/2022 - 03/2006
6	Transplantation 01/2019 - 11/2008
1	Activities of Daily Living (ADL) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Denervation 09/2010